Literature DB >> 18801759

Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease.

S Ozen1, N Aktay, E Lainka, A Duzova, A Bakkaloglu, T Kallinich.   

Abstract

BACKGROUND: Worldwide, familial Mediterranean fever (FMF) is the most common autoinflammatory disease. It has been suggested that environmental factors affect the phenotype as some patients do not develop the complication of secondary amyloidosis.
OBJECTIVE: To analyse whether disease severity in Turkish children with FMF, living in Turkey and Germany is different. PATIENTS AND METHODS: A total of 55 Turkish children living in Turkey were compared with 45 Turkish children born and raised in Germany. Mean age among the group from Turkey and Germany was 42.2 and 44.29 months, respectively. M694V was the leading mutation in both groups. The severity scores were compared with two scoring systems, modified according to published paediatric data for dosage.
RESULTS: There was no significant difference between the mean C-reactive protein and erythrocyte sedimentation rate levels of the two groups. According to the modified Sheba Center score, 78.2% of patients from the group living in Turkey had a severe course compared with 34.1% from the group living in Germany. The modified score of Pras et al also showed more severe disease in the patients from Turkey. The difference between the two groups for both scoring systems were significant (both p<0.05).
CONCLUSIONS: We believe the modified scores that we introduce can be widely used for children. Our results suggest that the environment affects the phenotype of a monogenic disease of the innate inflammatory pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801759     DOI: 10.1136/ard.2008.092031

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Diagnosis. Severity scoring system for paediatric FMF.

Authors:  Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

Review 2.  The myths we believed in familial Mediterranean fever: what have we learned in the past years?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Semin Immunopathol       Date:  2015-04-02       Impact factor: 9.623

3.  Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better?

Authors:  Victoria Akse-Onal; Erdal Sağ; Seza Ozen; Aysin Bakkaloglu; Nilgun Cakar; Nesrin Besbas; Safak Gucer
Journal:  Eur J Pediatr       Date:  2010-02-24       Impact factor: 3.183

Review 4.  [Role of genetics in familial Mediterranean fever].

Authors:  T Kallinich; B Orak; H Wittkowski
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

5.  Severity scoring system for paediatric FMF.

Authors:  Gokhan Kalkan; Erkan Demirkaya; Seza Ozen
Journal:  Nat Rev Rheumatol       Date:  2012-09-11       Impact factor: 20.543

6.  Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever.

Authors:  Nuray Aktay Ayaz; Ayşe Tanatar; Şerife Gül Karadağ; Mustafa Çakan; Gonca Keskindemirci; Hafize Emine Sönmez
Journal:  Rheumatol Int       Date:  2020-04-28       Impact factor: 2.631

7.  Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center.

Authors:  Ayşe Tanatar; Hafize Emine Sönmez; Şerife Gül Karadağ; Figen Çakmak; Mustafa Çakan; Ferhat Demir; Betül Sözeri; Nuray Aktay Ayaz
Journal:  Rheumatol Int       Date:  2019-10-23       Impact factor: 2.631

8.  Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence.

Authors:  Arnd Giese; Mustafa Kurucay; Levent Kilic; Ahmet Örnek; Süleyman Nahit Şendur; Elke Lainka; Bernhard Ferdinand Henning
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

9.  Bile acid analogues are activators of pyrin inflammasome.

Authors:  Irina Alimov; Suchithra Menon; Nadire Cochran; Rob Maher; Qiong Wang; John Alford; John B Concannon; Zinger Yang; Edmund Harrington; Luis Llamas; Alicia Lindeman; Gregory Hoffman; Tim Schuhmann; Carsten Russ; John Reece-Hoyes; Stephen M Canham; Xinming Cai
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

10.  Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population.

Authors:  E Lainka; M Bielak; P Lohse; C Timmann; S Stojanov; R von Kries; T Niehues; U Neudorf
Journal:  Eur J Pediatr       Date:  2012-08-19       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.